Postmarketing surveillance study of erlotinib plus gemcitabine for pancreatic cancer in Japan: POLARIS final analysis

OBJECTIVE: Erlotinib plus gemcitabine is approved in Japan for the treatment of metastatic pancreatic cancer. The POLARIS surveillance study investigated safety (focusing on interstitial lung disease [ILD]) and efficacy of erlotinib plus gemcitabine in Japanese pancreatic cancer patients. METHODS: P...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Jpn J Clin Oncol
Main Authors: Furuse, Junji, Gemma, Akihiko, Ichikawa, Wataru, Okusaka, Takuji, Seki, Akihiro, Ishii, Tadashi
Format: Artigo
Sprog:Inglês
Udgivet: Oxford University Press 2017
Fag:
Original Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5896695/
https://ncbi.nlm.nih.gov/pubmed/28541474
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jjco/hyx075
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker